Q3 2026 lobbying Filed Oct 20
Q3 spend$50KQ2 $50K
QoQ0.0%vs Q2 2026
YoY0.0%vs Q3 2025
AgenciesCongress onlyHouse, Senate
HCRHealth IssuesMMMMedicare/Medicaid
Lobbied on Non-opioid alternatives reimbursement; Coverage decisions anti nausea treatments; non-opioid alternatives reimbursement; Coverage decisions anti nausea treatments
Bills No bills named in Q3 2026 filings
No member trades in 90 days Stock page ›